Paper20180652
Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.
Boyer JL and 7 others. Hum Gene Ther, 2010. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid. Papers, record 20180652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20180652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoviridae | Major topic |
| Antigens, Bacterial | Major topic |
| Bacterial Proteins | Major topic |
| Bacterial Vaccines | Major topic |
| Capsid | Major topic |
| Plague | Major topic |
| Pore Forming Cytotoxic Proteins | Major topic |
| Yersinia pestis | Major topic |
| Blotting, Western | |
| Genetic Vectors | |
| Immunization | |
| Recombinant Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U54 AI057158 | NIAID NIH HHS | United States | U54AI057158 | PubMed and NIH |
Source NIH RePORTER
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17966437 | Protective immunity against plague. | Adv Exp Med Biol | 2007 | https://conductscience.org/library/papers/17966437 | PubMed |
| 2 | 17287055 | A plant-produced plague vaccine candidate confers protection to monkeys. | Vaccine | 2007 | https://conductscience.org/library/papers/17287055 | PubMed |
| 3 | 16243411 | Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. | Vaccine | 2006 | https://conductscience.org/library/papers/16243411 | PubMed |
| 4 | 17376861 | Development of in vitro correlate assays of immunity to infection with Yersinia pestis. | Clin Vaccine Immunol | 2007 | https://conductscience.org/library/papers/17376861 | PubMed |
| 5 | 9660466 | Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. | Am J Trop Med Hyg | 1998 | https://conductscience.org/library/papers/9660466 | PubMed |
| 6 | 19124600 | Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge. | Infect Immun | 2009 | https://conductscience.org/library/papers/19124600 | PubMed |
| 7 | 9334364 | Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. | J Exp Med | 1997 | https://conductscience.org/library/papers/9334364 | PubMed |
| 8 | 11779413 | Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. | Hum Gene Ther | 2002 | https://conductscience.org/library/papers/11779413 | PubMed |
| 9 | 8892868 | Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. | J Virol | 1996 | https://conductscience.org/library/papers/8892868 | PubMed |
| 10 | 15996701 | Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion. | Virology | 2005 | https://conductscience.org/library/papers/15996701 | PubMed |
| 11 | 1370653 | In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. | Cell | 1992 | https://conductscience.org/library/papers/1370653 | PubMed |
| 12 | 11356075 | Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. | Mol Ther | 2001 | https://conductscience.org/library/papers/11356075 | PubMed |
| 13 | 13808585 | The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. | J Immunol | 1959 | https://conductscience.org/library/papers/13808585 | PubMed |
| 14 | 19200825 | A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague. | Vaccine | 2009 | https://conductscience.org/library/papers/19200825 | PubMed |
| 15 | 11863421 | Effect of adenovirus gene transfer vectors on the immunologic functions of mouse dendritic cells. | Mol Ther | 2002 | https://conductscience.org/library/papers/11863421 | PubMed |
| 16 | 17416264 | Plague. | Lancet | 2007 | https://conductscience.org/library/papers/17416264 | PubMed |
| 17 | 11779412 | Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. | Hum Gene Ther | 2002 | https://conductscience.org/library/papers/11779412 | PubMed |
| 18 | 18324890 | Current challenges in the development of vaccines for pneumonic plague. | Expert Rev Vaccines | 2008 | https://conductscience.org/library/papers/18324890 | PubMed |
| 19 | 12072490 | Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. | J Virol | 2002 | https://conductscience.org/library/papers/12072490 | PubMed |
| 20 | 15841217 | Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15841217 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42576894 | Anti-infective compounds for Yersinia. | Sustain Microbiol | 2026 | https://conductscience.org/library/papers/42576894 | PubMed |
| 39242587 | Progress on the research and development of plague vaccines with a call to action. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/39242587 | PubMed |
| 33514747 | A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/33514747 | PubMed |
| 30049954 | Progress in Adenoviral Capsid-Display Vaccines. | Biomedicines | 2018 | https://conductscience.org/library/papers/30049954 | PubMed |
| 29725025 | Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. | Sci Rep | 2018 | https://conductscience.org/library/papers/29725025 | PubMed |
| 28362809 | Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform. | PLoS One | 2017 | https://conductscience.org/library/papers/28362809 | PubMed |
| 28207901 | YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection. | PLoS One | 2017 | https://conductscience.org/library/papers/28207901 | PubMed |
| 28018363 | Plague Vaccine Development: Current Research and Future Trends. | Front Immunol | 2016 | https://conductscience.org/library/papers/28018363 | PubMed |
| 27722869 | Plague Vaccines: Status and Future. | Adv Exp Med Biol | 2016 | https://conductscience.org/library/papers/27722869 | PubMed |
| 25703559 | B cells and antibodies in the defense against Mycobacterium tuberculosis infection. | Immunol Rev | 2015 | https://conductscience.org/library/papers/25703559 | PubMed |
| 24981329 | The effect of fiber truncations on the stability of adenovirus type 5. | Mol Biotechnol | 2014 | https://conductscience.org/library/papers/24981329 | PubMed |
| 24444179 | Adenovirus: the first effective in vivo gene delivery vector. | Hum Gene Ther | 2014 | https://conductscience.org/library/papers/24444179 | PubMed |
| 23707160 | Prospects for oral replicating adenovirus-vectored vaccines. | Vaccine | 2013 | https://conductscience.org/library/papers/23707160 | PubMed |
| 22089246 | Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity. | Clin Vaccine Immunol | 2012 | https://conductscience.org/library/papers/22089246 | PubMed |
| 21918302 | Developing live vaccines against plague. | J Infect Dev Ctries | 2011 | https://conductscience.org/library/papers/21918302 | PubMed |
| 21130482 | Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors. | Virology | 2011 | https://conductscience.org/library/papers/21130482 | PubMed |
| 21047139 | Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach. | Mol Pharm | 2011 | https://conductscience.org/library/papers/21047139 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20180652
GET https://conductscience.org/api/papers/v1/20180652/references?page=2